Quantcast
Channel: Contract Pharma - Trials & Filings
Browsing latest articles
Browse All 170 View Live

GSK NSCLC Drug Wins Breakthrough Status

FDA recognizes need for dabrafenib treatment

View Article



MEI Doses First MDS Patient

Tests pracinostat in patients failing HMA therapy

View Article

D-Pharm Recruits First Pancreatitis Patient

Ph II study to involve 30 patients

View Article

Nektar Doses First Patients in Neuropathic Pain Study

Testing pharmacokinetics of novel pain-blocker

View Article

MediciNova Posts Strong NASH Results

Preclinical tests in mice lead to Ph II plans

View Article


BioMarin Begins Dwarfism Trial

Tests CNP analog against achondoplasia in children

View Article

AbbVie Begins Triple-Negative Breast Cancer Trial

Veliparib to be added to carboplatin in Ph III trial

View Article

Galectin Drug in Early Test Against Melanoma

EACRI to test galectin-3 inhibitor with Yervoy in metastatic melanoma

View Article


La Jolla Launches Extension Study

12-week program continues with CKD patients

View Article


Antarex MTX Auto-Injector Reaches Market

Otrexup approved in October 2013 for RA, pJIA

View Article

Dosing Begins in Elite Bioequivalence Study

Camargo conducts abuse-deterrence study under 505(b)2

View Article

Gilead\'s Sovaldi Gains EU Approval

Authorization follows accelerated EMA assessment

View Article

Merrimack Initiates Phase I MM-398 Trial

To evaluate cyclophosphamide combination in pediatric tumors

View Article


Amgen’s Phase III Evolocumab Trial Meets Endpoints

Reduces LDL-C in statin intolerant patients

View Article

Pfizer\'s Phase III ALO-02 Trial Meets Endpoint

Demonstrates statistically significant benefit

View Article

Browsing latest articles
Browse All 170 View Live




Latest Images